F. HOFFMANN-LA ROCHE AG has a total of 28 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2002. It filed its patents most often in Hong Kong, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PFIZER, BOEHRINGER INGELHEIM PHARMA and ACEA PHARM INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Hong Kong | 13 | |
#2 | Australia | 12 | |
#3 | Canada | 1 | |
#4 | Peru | 1 | |
#5 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Packaging and shipping | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Syringes | |
#7 | Packaging | |
#8 | Unspecified technologies | |
#9 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Heinz Stadler | 3 |
#2 | Thierry Godel | 3 |
#3 | Walter Hunkeler | 3 |
#4 | Torsten Hoffmann | 3 |
#5 | Michael Boes | 3 |
#6 | Guido Galley | 3 |
#7 | Patrick Schnider | 3 |
#8 | Grillo-Lopez Antonio | 2 |
#9 | Leo Alig | 2 |
#10 | Kurt Hilpert | 2 |
Publication | Filing date | Title |
---|---|---|
AU2008300649A1 | Prodrugs to thyroid hormone analogs | |
AU2005211669A1 | Treatment of intermediate- and high-grade non-Hodgkins lymphoma with anti-CD20 antibody |